Avacta Therapeutics Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Avacta is a clinical-stage biotechnology company based in London, England, focused on advancing cancer therapies through its pre|CISION platform. The platform is described as tumor-activated, reflecting an emphasis on targeted oncology delivery. With a relatively small team, the company operates in the biotechnology research sector pursuing clinical development in cancer therapies. The overarching aim is to expand the reach of potent cancer therapies through its platform. Recent activity includes Avacta planning to present preclinical and translational data on pre|CISION platform candidates at the AACR Annual Meeting 2026. This indicates continued progress in its clinical-stage oncology delivery program.